UNSPSC 51263301: Nafetolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C19H29NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier MAL2XF17MP, chemically known as 1,4-ethanonaphthalen-5-ol, 8-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-1,2,3,4-tetrahydro-, but generally known as nafetolol, which bears US NIH Compound Identifier 68668. European Medicines Agency schedules Nafetolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09121MIG.

UNSPSC 51263301 Nafetolol, a Commodity code, represents pharmaceutical products and substances that state and local governments procure for public health and emergency-response programs. The recent record under this code shows procurement of naloxone and drug deactivation systems rather than nafetolol specifically, indicating that the code may be applied more broadly to opioid-antagonist and harm-reduction pharmaceuticals than its nominal name suggests. State and local issuing bodies soliciting under this code include county health departments and community health programs focused on overdose prevention and substance-abuse mitigation.

Seminole County, Florida posted an IFB (Invitation for Bid) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a response deadline of July 26, 2023. The contract carries a two-year initial term with a one-year renewal option, requires E-Verify compliance and drug-free workplace certification, and was potentially funded through FEMA, introducing additional federal compliance requirements. The recent-opportunities block contains only this single solicitation, offering limited visibility into geographic spread or repeat-buyer patterns across state and local jurisdictions.